Challenging orthodoxy in critical care trial design: Physiological responsiveness

Annals of Translational Medicine

Volumn 4, Issue 7, 2016, Pages

  Aberegg, Scott ^a  

^a Valley Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL (TOPIC); CRITICALLY ILL PATIENT; DATA ANALYSIS; DISEASE SEVERITY; EFFECT SIZE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FRAUD; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; INTENSIVE CARE; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; MULTICENTER STUDY (TOPIC); NOTE; OUTCOME ASSESSMENT; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SHOCK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVOR; SYSTEMATIC ERROR; TREATMENT OUTCOME;

EID: 85006219617     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.03.45     Document Type: Note

References (39)

1. Oba Y, Salzman GA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury. N Engl J Med 2000;343:813; author reply 813-4.
2. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
3. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738-48.
4. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
5. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
6. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353:1332-41.
7. Ranieri VM, Thompson BT, Barie PS, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012;366:2055-64.
8. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
9. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56.
10. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63.
11. Moler FW, Silverstein FS, Holubkov R, et al. Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med 2015;372:1898-908.
12. Mourvillier B, Tubach F, van de Beek D, et al. Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 2013;310:2174-83.
13. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
14. ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371:1496-506.
15. Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015;372:1301-11.
16. Browner WS, Newman TB. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. JAMA 1987;257:2459-63.
17. Halsey LG, Curran-Everett D, Vowler SL, et al. The fickle P value generates irreproducible results. Nat Methods 2015;12:179-85.
18. Curran-Everett D. Explorations in statistics: hypothesis tests and P values. Adv Physiol Educ 2009;33:81-6.
19. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
20. Alberts B, Cicerone RJ, Fienberg SE, et al. SCIENTIFIC INTEGRITY. Self-correction in science at work. Science 2015;348:1420-2.
21. Open Science Collaboration. PSYCHOLOGY. Estimating the reproducibility of psychological science. Science 2015;349:aac4716.
22. Kerry R, Eriksen TE, Lie SA, et al. Causation and evidence-based practice: an ontological review. J Eval Clin Pract 2012;18:1006-12.
23. Weil MH. Lessons learned from clinical trials on monoclonal anti-endotoxin antibody. Arch Intern Med 1994;154:1183.
24. Aberegg S. Quality-adjusted life years or composite outcomes? Am J Respir Crit Care Med 2013;188:622.
25. Freiman JA, Chalmers TC, Smith H Jr, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
26. Aberegg SK, Richards DR, O'Brien JM. Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care 2010;14:R77.
27. Steinbrook R. How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome. N Engl J Med 2003;348:1393-401.
28. Burke JF, Hayward RA, Nelson JP, et al. Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials. Circ Cardiovasc Qual Outcomes 2014;7:163-9.
29. Wang H, Boissel JP, Nony P. Revisiting the relationship between baseline risk and risk under treatment. Emerg Themes Epidemiol 2009;6:1.
30. Beesley SJ, Lanspa MJ. Why we need a new definition of sepsis. Ann Transl Med 2015;3:296.
31. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-33.
32. Fröhlich S, Murphy N, Boylan JF. ARDS: progress unlikely with non-biological definition. Br J Anaesth 2013;111:696-9.
33. Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015;372:1629-38.
34. Goligher EC, Kavanagh BP, Rubenfeld GD, et al. Physiologic Responsiveness Should Guide Entry into Randomized Controlled Trials. Am J Respir Crit Care Med 2015;192:1416-9.
35. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006;354:1775-86.
36. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.
37. Montori VM, Kleinbart J, Newman TB, et al. Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals). CMAJ 2004;171:611-5.
38. Ferguson ND, Scales DC, Pinto R, et al. Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials. Am J Respir Crit Care Med 2013;187:256-61.
39. Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311:1308-16.